AstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine using a lower dosage amid questions over the results from its late-stage study
from Latest News https://ift.tt/3lcYbNE
Thursday, 26 November 2020
CEO says AstraZeneca may to run new global trial of Covid vaccine: Report
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment